Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella
Conditions
Interventions
- BIOLOGICAL: Measles and Rubella vaccine
- BIOLOGICAL: Measles, Mumps and Rubella vaccine
Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Collaborators